{"denoms":[{"counts":[{"groupId":"BG000","value":"43"}],"units":"Participants"}],"groups":[{"description":"Ixazomib 4 mg, capsules, orally, once on Days 1, 8, and 15; lenalidomide 25 mg, capsules, orally, once on Days 1 through 21; and dexamethasone 40 mg, tablets, orally, once on Days 1, 8, 15, and 22 of a 28-day treatment cycle until progressive disease (PD) or unacceptable toxicity (up to 20 cycles)","id":"BG000","title":"Ixazomib+Lenalidomide+Dexamethasone"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.84","value":"61.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"27"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}]}],"title":"Not Hispanic or Latino"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}]}],"title":"Asian"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}]}],"title":"Singapore"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Hong Kong"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}]}],"title":"Korea, Republic Of"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.80","value":"160.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Height at Baseline","unitOfMeasure":"cm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.47","value":"60.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight at Baseline","unitOfMeasure":"kg"}],"populationDescription":"Safety Population included all participants who received at least one dose of study drug."}